Site Management/Investigator Payments Featured Articles

1. Inside The Trials Aiming To Stop Vision Loss For Rare Eye Disease Patients 5/27/2025

   Ocugen Chief Medical Officer Huma Qamar, MD, MPH, CMI, discusses two rare disease trials and how the company's managed their protocol design, PI selection, and patient recruitment.

2. Spiders, Mold, & SOPs: Tales From A Site Inspection Veteran 5/22/2025

   Sarah Moeller, a veteran of mock regulatory inspections, shares lessons from over 300 site visits, emphasizing preparation, documentation, and patient-focused practices to ensure sites are inspection-ready.

3. How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two 5/19/2025

   Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI.

4. Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One 5/19/2025

   Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards. 

5. Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake 5/16/2025

   How much are clinical research sites using AI? And how can sponsors and CROs effectively support sites in doing so? Consultant Maria P. Ladd explains.

6. 5 Ways AI Is Changing Clinical Research — And How To Embrace It 5/15/2025

   Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.

7. 3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization 5/13/2025

   CTMC's Amy Hay provides 3 recommendations for teams developing cell and gene therapies, from clinical research through commercialization.

8. The Potential Impact Of U.S. Tariffs On The Biotech Sector: Manufacturing, Funding, And Clinical Trials 5/12/2025

   Syner-G Biopharma Group's Raymond Forslund, Ph.D., MBA explores how U.S. tariffs might affect biotech manufacturing, funding, and clinical research.

9. The Risk And Reward Of Clinical Investigators Integrating AI 5/1/2025

   Husch Blackwell LLP experts discuss relevant regulatory frameworks and the risks and liabilities of clinical investigators using AI.

10. Run Better Trials By Rewriting The CRA-Site Relationship Playbook 4/29/2025

    Senior CRA Bryce Nichols explains how sites can use their CRAs — beyond their monitoring duties — to improve site efficiency, communication, and trial success.